Abbott (NYSE:ABT) today announced late-breaking data from the LIFE-BTK clinical trial evaluating the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK) in people with chronic limb-threatening
Tigo Energy, Inc. (NASDAQ:TYGO) ("TYGO" or the "Company") today announced that it will redeem all of its outstanding public warrants and private warrants (together, the "Warrants") to purchase shares of the Company's
Marlboro maker Altria Group Inc (NYSE:MO) reported a second-quarter FY22 sales decline of 5.7% year-on-year, to $6.54 billion, beating the consensus of…